Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report.

We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under-recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.